Kolkata: The medics warned that India could be the Capital of Diabetic in the World if care of the health is not taken in time as the recent research study surely indicated that an increasing number of diabetics following Covid-19 infections in the country.
The doctors say that many patients with coronavirus disease (Covid-19) come to hospitals with severe diabetic crises, as diabetes can be triggered by stress to the body during the Covid-19 infection.
"It's been reported that there has been a definite increase in the number of diabetes cases during the pandemic, the use of steroids (Corticosteroids) in the treatment, and the sedentary lifestyle adds on to the increasing numbers. Now, there is also a discussion of Covid-19 directly affects the beta cells in the pancreas as they have the ACE II receptors used by the Sars-CoV-2 virus," the study says.
In today's world, approximately 422 million people are living with diabetes all over the world, among them 77 million are affected in India.
Diabetes is one of the most serious chronic non-communicable diseases plaguing millions of people in such a way, by 2045 it is expected to see a rise of 76 per cent in the Diabetic Population, which will soon make our country the Diabetic Capital of the world surpassing China.
The theme for World Diabetes Month 2021 is “Access to Diabetes Care” – in the hope that India can also become the Diabetic Care Capital of the world too. The year 2021 is also special because it marks 100 years of discovery of insulin.
"We have previously reported the impact of this lockdown on worsening of HBA1c and the associated complications in type 2 diabetes mellitus probably due to the restriction of movement, limited exercise, improper diet, and psychological stress. This is especially important for Asian Indians where the rate of conversion to T2DM from the pre-diabetes state is higher as 50 pc of our population (below 50 years of age) is getting affected with Diabetes. Such an increment in the number of patients with diabetes in India would be catastrophic because of further addition to a large pool of patients.” Suparna Sengupta, CEO, Narayan Memorial Hospital, said.
Sharing his views, Dr Sujit Bhattacharya, - MD, DNB, MNAMS, DM (PGI) MRCP said, “Insulin has been available for the treatment of diabetes for almost 100 years, transforming the lives of people with diabetes, changing the diagnosis from a death sentence to living with a manageable long-term condition. Therapeutic insulin has evolved from a crude extract of the animal pancreas to recombinant human insulin and insulin analogues. The time-action profiles of insulin and formulations have been intentionally modified over the years to more closely mimic the endogenous insulin response. There are more developments on the horizon, too.”
“It has been seen that there is a rise of 48pc of Post Prandial blood glucose levels in Diabetic Population due to the ongoing pandemic. This rise is predicted to be due to lack of exercise, intermittent snacking, work-from-home culture and more consumption of fast food, ordered food. Similarly only 18.7pc of individuals are adopting healthier ways of living. But we aim to determine the risk in non-diabetic individuals as well and also to make them aware of its long term health implications,” Dr Ipsita Ghosh - MD said. (UNI)
